Table 2.
Use of antiepileptic drugs and mood-stabilising medicines in women of childbearing age
| AED or MSM used | 2015a (%)b | 2016a (%)b | 2017a (%)b |
|---|---|---|---|
| Sodium valproate | 8205 (43.2) | 9425 (45.5) | 9902 (44.8) |
| Carbamazepine | 4874 (25.7) | 4930 (23.8) | 5001 (22.6) |
| Risperidone | 4162 (21.9) | 4906 (23.7) | 5308 (24.0) |
| Phenytoin | 3653 (19.3) | 3505 (16.9) | 3284 (14.8) |
| Lamotrigine | 1482 (7.8) | 1673 (8.1) | 1962 (8.9) |
| Olanzapine | 992 (5.2) | 1374 (6.6) | 1813 (8.2) |
| Lithium | 903 (4.8) | 1024 (4.9) | 1042 (4.7) |
| Levetiracetam | 64 (0.8) | 65 (0.3) | 88 (0.4) |
| Total number of WOCBA taking AEDs or MSMs (%) | 18,974 (1.82c) | 20,701 (2.06c) | 22,120 (2.03c) |
| Total number of WOCBA not taking AEDs or MSMs | 1,025,847 | 985,147 | 1,069,598 |
| Total number of WOCBA | 1,044,821 | 1,005,847 | 1,091,718 |
AEDs antiepileptic drugs, MSMs mood-stabilising medicines, WOCBA women of childbearing age
a Many women were exposed to more than one AED or MSM, either concurrently or consecutively, during the course of each year
b Percentage of all WOCBA taking either an AED or an MSM
c Percentage of all WOCBA